Stock

NBIX US

NEUROCRINE BIOSCIENCES INC · NASDAQ · USD · Healthcare

Heavy insider selling $6.2M (90d)

$138.40

-0.54 (-0.39%)

Price session: 2026-09-25 · Observed: 25 Sept 2026, 23:00 KSA · Source: delayed quote

Easy Score

Weak

Value

Momentum

Trend

Three engines, 0–100 each. Analysis, not financial advice.

Why is it moving?auto-generated

NBIX -0.39% today · volume in line with average · RSI depressed at 26 · 1 recent headline — latest not assessed: “Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit”.

Latest headlines

• Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit

Priceinteractive — your checked tools draw on it

Daily is the finest granularity · last ~6 months

RSI (14)

Patterns detected:

CloseMA 50MA 200check tools below to add them to the chart

Key technicals & risksame engine as the score

RSI (14)

25.6

MACD hist.

-1.32

50-day MA

$158.96

200-day MA

$147.61

ATR (14)

$3.99

Avg volume (20d)

1.2M

Volatility

33%

Max drawdown

-25%

Beta vs S&P

0.66

Daily plain-language briefs are a Pro feature.

Signal mix18

bullish

neutral

bearish

Every tool the engine can compute from stored bars. Check tools on the chart to see each one.

Street consensus36 analysts

Buy31

Hold5

Sell0

Forecast two independent reads

System

USD 134.95USD 142.65

Yours · 2 tools

USD 137.11USD 144.93

Model anchor (last stored close)

USD 138.40

USD 134.36USD 145.52

Computed from: USD 138.40 · session 2026-09-25 · 2509 historical windows

Lean score +0.57 — 1 bullish / 0 bearish / 1 neutral among your checked tools, weighted for this horizon. Your overlay is an exploratory scenario, not a calibrated prediction. The historical baseline stays unchanged. The system band is the 25th–75th percentile of this stock’s own historical moves for the horizon.